MangoRx Gets Patent Notice Of Allowance In Japan For Revolutionary Preventive Care Technology
Portfolio Pulse from Benzinga Newsdesk
Mangoceuticals, Inc. (NASDAQ:MGRX) has received a Notice of Allowance for a Japanese patent application for its preventive care technology. This follows the company's acquisition of a global patent portfolio from Intramont Technologies, expanding its protection for formulations combating infections.
June 04, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mangoceuticals, Inc. (NASDAQ:MGRX) has received a Notice of Allowance for a Japanese patent application for its preventive care technology. This follows the company's acquisition of a global patent portfolio from Intramont Technologies, expanding its protection for formulations combating infections.
The Notice of Allowance for the Japanese patent application is a significant milestone for Mangoceuticals, as it expands the company's intellectual property protection in a major market. This development is likely to positively impact the stock price in the short term due to the enhanced market potential and competitive edge.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100